Empliciti and Vigamox drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported only by a few people who take Empliciti and Vigamox together.
The phase IV clinical study analyzes what interactions people who take Empliciti and Vigamox have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Empliciti and Vigamox together, and have interactions are studied.
What is Empliciti?
Empliciti has active ingredients of elotuzumab. eHealthMe is studying from 2,235 Empliciti users for its effectiveness, alternative drugs and more.
What is Vigamox?
Vigamox has active ingredients of moxifloxacin hydrochloride. It is often used in conjunctivitis. eHealthMe is studying from 2,659 Vigamox users for its effectiveness, alternative drugs and more.
Number of Empliciti and Vigamox reports submitted per year:
Common Empliciti and Vigamox drug interactions by gender *:
* Approximation only. Some reports may have incomplete information.
Do you take Empliciti and Vigamox?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Empliciti and Vigamox:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Empliciti side effects:
- Death: 203 reports
- Fatigue (feeling of tiredness): 142 reports
- Diarrhea: 126 reports
- Multiple myeloma (cancer of the plasma cells): 121 reports
Browse all side effects of Empliciti:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Vigamox side effects:
- Chronic kidney disease: 236 reports
- Eye pain: 175 reports
- Acute kidney failure: 168 reports
- Endophthalmitis (inflammation of the internal coats of the eye): 148 reports
- Pain: 136 reports
- Cataract (clouding of the lens inside the eye): 119 reports
- Drug ineffective: 113 reports
Browse all side effects of Vigamox:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Empliciti interactions:
- Empliciti and Revlimid: 849 reports
- Empliciti and Pomalyst: 493 reports
- Empliciti and Aspirin: 343 reports
- Empliciti and Dexamethasone: 198 reports
- Empliciti and Velcade: 165 reports
- Empliciti and Pomalidomide: 141 reports
- Empliciti and Vitamin d: 134 reports
- Empliciti and Gabapentin: 133 reports
- Empliciti and Zometa: 126 reports
- Empliciti and Magnesium: 101 reports
Browse all interactions between Empliciti and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Vigamox interactions:
- Vigamox and Prednisone: 340 reports
- Vigamox and Aspirin: 333 reports
- Vigamox and Nexium: 317 reports
- Vigamox and Nevanac: 275 reports
- Vigamox and Lisinopril: 246 reports
- Vigamox and Prednisolone acetate: 226 reports
- Vigamox and Tramadol: 221 reports
- Vigamox and Furosemide: 215 reports
- Vigamox and Omeprazole: 207 reports
- Vigamox and Prednisolone: 205 reports
Browse all interactions between Vigamox and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on elotuzumab and moxifloxacin hydrochloride (the active ingredients of Empliciti and Vigamox, respectively), and Empliciti and Vigamox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Empliciti and Vigamox.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cardizem and Gamma-Glutamyltransferase Increased - 48 seconds ago
- Cyclosporine and Nausea And Vomiting - 50 seconds ago
- Hodgkin'S Lymphoma and Febrile Infection - 52 seconds ago
- Livostin and Levonorgestrel drug interaction - 54 seconds ago
- Fentanyl-100 and Aplastic Anemia - a minute ago
- Gout in Flomax, how severe and when it was recovered? - 2 minutes ago
- Novalgin and Gastroenteritis Salmonella - 2 minutes ago
- Lacosamide and Pollakiuria - 2 minutes ago
- Levoxyl and Bone Marrow Oedema - 3 minutes ago
- Nifedipine and Epstein-Barr Virus Associated Lymphoproliferative Disorder - 3 minutes ago